Skip to main content

Table 1 Clinical characteristics of study population

From: The use of Transcollation Technology for Video-Assisted Thoracic Surgery lobectomy

Variables All patients TT Group TE Group p
Number 53 24 29
Age 63.7 ± 4.9 64.2 ± 3.9 62.1 ± 4.5 0.74
Gender (male) 35 (66%) 16 (67%) 19 (65%) 0.85
BMI 25 ± 8.1 24.9 ± 2.8 25.1 ± 3.1 0.65
Charlson index 2.89 ± 0.7 2.8 ± 0.3 2.77 ± 0.3 0.69
Lung Function
 • ppoFEV1% 85.9 ± 3.9 85 ± 4.9 86 ± 3.5 0.87
 • ppoDLCO% 82.7 ± 6.9 81.7 ± 8.3 82 ± 6.5 0.75
Pathologic Stage
 • I 33 (62%) 15 (61%) 18 (69%) 0.82
 • II 11 (21%) 5 (31%) 6 (22%) 0.98
 • III 9 (17%) 4 (8%) 5 (9%) 0.95
Histology
 • Adenocarcinoma 40 (75%) 19 (79%) 21 (72%) 0.57
 • Squamous cell carcinoma 11 (21%)
2 (4%)
5 (21%)
0
6 (21%)
2 (7%)
0.98
0.19
 • Others     
Surgery
 • Uniportal- VATS 25 (47%) 11 (46%) 14 (48%) 0.86
 • Triportal VATS 28 (53%) 13 (54%) 15 (52%) 0.86
  1. Abbreviations: TT Group transcollation technology group, TE Group traditional electrocautery group, BMI body mass index, FEV1 forced expiratory volume in 1 s, DLCO carbon monoxide diffusing capacity, VATS video-assisted thoracic surgery